Literature DB >> 18492848

C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet.

David R Archer1, Jonathan K Stiles, Gale W Newman, Alexander Quarshie, Lewis L Hsu, Phouyong Sayavongsa, Jennifer Perry, Elizabeth M Jackson, Jacqueline M Hibbert.   

Abstract

Sickle cell disease is associated with hypermetabolism and a consequent shortage of substrates for normal growth and healthy immune response. The protein:energy ratio is a major determinant of dietary adequacy; the requirement for optimal growth of control mice is 20% of energy from dietary protein. This study investigated the efficacy of increased dietary protein for improving weight gain and reducing inflammation in the Berkeley sickle cell mouse model (S). The study examined the effect of diet on weight gain and circulating levels of 2 inflammatory proteins, C-reactive protein (CRP), and cytokine interleukin-6 (IL-6). Male C57BL/6 (C) control (n = 8) and S mice (n = 8) were randomized at weaning to 40 d of isoenergetic diets containing 20% (normal) and 35% (high) of energy from protein (C20, C35, S20, S35), replacing dextrin. Rate of weight gain was calculated and plasma CRP and IL-6 concentrations determined by ELISA. Liver mRNA expression of these proteins was measured by real-time PCR and L-arginase by colorimetric assay. S35 mice tended to gain weight more rapidly than S20 mice (P = 0.06) and more rapidly than C35 mice (P < 0.01). Circulating CRP and IL-6 levels were also lower in S35 mice than in S20 mice (P < 0.05), as was liver CRP mRNA expression (P < 0.01). These results demonstrate that introducing a high protein diet at weaning attenuates the steady-state inflammation in this S mouse model. Dietary L-arginine availability was investigated as a possible mechanism for increased nitric oxide production and consequent reduced inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492848      PMCID: PMC3755955          DOI: 10.1093/jn/138.6.1148

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  42 in total

1.  Evidence for a metabolic shift of arginine metabolism in sickle cell disease.

Authors:  John-John B Schnog; Esther H Jager; Fey P L van der Dijs; Ashley J Duits; Han Moshage; Fred D Muskiet; Frits A J Muskiet
Journal:  Ann Hematol       Date:  2004-03-31       Impact factor: 3.673

2.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

3.  Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study.

Authors:  G R Serjeant; A Singhal; I R Hambleton
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

4.  Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.

Authors:  M Aslan; T M Ryan; B Adler; T M Townes; D A Parks; J A Thompson; A Tousson; M T Gladwin; R P Patel; M M Tarpey; I Batinic-Haberle; C R White; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Growth deficits in children with sickle cell disease.

Authors:  Célia Maria Silva; Marcos Borato Viana
Journal:  Arch Med Res       Date:  2002 May-Jun       Impact factor: 2.235

6.  Urea kinetics: comparison of oral and intravenous dose regimens.

Authors:  J M Hibbert; T Forrester; A A Jackson
Journal:  Eur J Clin Nutr       Date:  1992-06       Impact factor: 4.016

7.  Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease.

Authors:  Atul Singhal; Stephany Parker; Louise Linsell; Graham Serjeant
Journal:  Am J Clin Nutr       Date:  2002-06       Impact factor: 7.045

8.  Hypoxia-induced acute lung injury in murine models of sickle cell disease.

Authors:  Kirkwood A Pritchard; Jingsong Ou; Zhijun Ou; Yang Shi; James P Franciosi; Paul Signorino; Sushma Kaul; Cathleen Ackland-Berglund; Karin Witte; Sandra Holzhauer; Narla Mohandas; Karen S Guice; Keith T Oldham; Cheryl A Hillery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-12       Impact factor: 5.464

9.  Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease.

Authors:  Vinod V Balasa; Karen A Kalinyak; Judy A Bean; Davis Stroop; Ralph A Gruppo
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

10.  Transgenic sickle mice have vascular inflammation.

Authors:  John D Belcher; Christopher J Bryant; Julia Nguyen; Paul R Bowlin; Miroslaw C Kielbik; John C Bischof; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

View more
  14 in total

Review 1.  New insights into the pathophysiology and development of novel therapies for sickle cell disease.

Authors:  Scott Moerdler; Deepa Manwani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemia.

Authors:  Elizabeth Ann Manci; Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Sydney Pitts; Samit Ghosh; John Patrickson; Michael E Titford; Solomon F Ofori-Acquah; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-19

3.  Malnutrition in Sickle Cell Anemia: Implications for Infection, Growth, and Maturation.

Authors:  Hyacinth I Hyacinth; Oluwatoyosi A Adekeye; Christopher S Yilgwan
Journal:  J Soc Behav Health Sci       Date:  2013-01-01

4.  Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Jennifer R Perry; Samit Ghosh; Prasanthi Chappa; Olufolake Adisa; Leslie S Kean; Solomon F Ofori-Acquah; David R Archer; Steven L Spitalnik; James C Zimring
Journal:  Transfusion       Date:  2011-07-25       Impact factor: 3.157

5.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26

6.  Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease.

Authors:  Kwaku Asare; Beatrice E Gee; Jonathan K Stiles; Nana O Wilson; Adel Driss; Alexander Quarshie; Robert J Adams; Abdullah Kutlar; Jacqueline M Hibbert
Journal:  Cytokine       Date:  2009-11-08       Impact factor: 3.861

7.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

8.  A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Authors:  Claudia R Morris; Frans A Kuypers; Lisa Lavrisha; Michael Ansari; Nancy Sweeters; Melinee Stewart; Ginny Gildengorin; Lynne Neumayr; Elliott P Vichinsky
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

9.  The Role of Nutrition in Sickle Cell Disease.

Authors:  H I Hyacinth; B E Gee; J M Hibbert
Journal:  Nutr Metab Insights       Date:  2010-01-01

10.  Pathophisiology of sickle cell disease and new drugs for the treatment.

Authors:  Lucia De Franceschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-20       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.